IGF2 and Hypoglycemia: In a previous extensive review of this topic by de Groot and coauthors in 2007, authors noted that 41% of the IGF-2 producing tumors causing hypoglycemia were of mesenchymal origin, 43% of epithelial origin, 1% of neuroendocrine and hematopoietic origin and 14% of unknown origin [2].